AMIX Autonomix Medical, Inc.


$ 1.05 $ 0.11 (12.37 %)    

Friday, 21-Nov-2025 11:35:16 EST
QQQ $ 587.84 $ 0.55 (0.09 %)
DIA $ 461.85 $ 2.38 (0.52 %)
SPY $ 657.21 $ 2.20 (0.34 %)
TLT $ 89.33 $ -0.33 (-0.37 %)
GLD $ 374.85 $ 0.86 (0.23 %)
$ na
$ 0.97
$ 1.04 x 535
$ 1.05 x 1,200
$ 0.97 - $ 1.05
$ 0.69 - $ 14.06
2,875,004
na
6.87M
$ -0.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to adv...

Core News & Articles

 With over 120 issued and pending patent applications, Autonomix is building a comprehensive, global IP portfolio in nerve-sens...

Core News & Articles

GLP study marks a key milestone in Autonomix's path to achieve regulatory approvalsCompany remains on track to submit Inves...

Core News & Articles

New longer-term post hoc analysis results of responders (n=6)1 showed long-lasting, durable pain reduction of nearly 66%, or a ...

Core News & Articles

On August 25, 2025, Autonomix Medical, Inc. (the "Company") entered into a purchase agreement, dated as of August 25, 2...

Core News & Articles

Global patent estate encompasses 80 issued patents and 40 pending patent applicationsStrengthens strategic position in a multi-...

Core News & Articles

Autonomix Medical (NASDAQ:AMIX) reported quarterly losses of $(1.07) per share which beat the analyst consensus estimate of $(1...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION